Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/31357
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.date.accessioned | 2023-03-06T07:50:07Z | - |
dc.date.available | 2023-03-06T07:50:07Z | - |
dc.date.issued | 2003 | - |
dc.identifier.citation | Baykara, M. vd. (2003). “The effect of anterior chamber maintainer on anterior chamber contamination”. European Journal of Ophthalmology, 13(9-10), 770-772. | en_US |
dc.identifier.issn | 1120-6721 | - |
dc.identifier.uri | https://doi.org/10.1177/1120672103013009-1006 | - |
dc.identifier.uri | https://journals.sagepub.com/doi/10.1177/1120672103013009-1006 | - |
dc.identifier.uri | http://hdl.handle.net/11452/31357 | - |
dc.description.abstract | PURPOSE. To evaluate the effect of anterior chamber continuous infusion maintainer system on the contamination of anterior chamber in phacoemulsification surgery. METHODS. Clear corneal phacoemulsification surgery was performed in 132 eyes of 132 randomly selected patients with cataract who were divided into two groups of 66 eyes according to the use of an anterior chamber maintainer (ACM) system. The fluid specimens were taken from anterior chamber in the beginning and at the end of the surgery. They were transferred under anaerobic conditions and investigated by culturing onto blood agar and thiogluconate broth media. Differences between the two groups with respect to contamination of the specimens were investigated. RESULTS. The mean age of the group undergoing surgery without a maintainer system (Group A) was 63 +/- 10 years (min = 41, max = 80) versus 59 +/- 10 years (min = 33, max = 80) in the other group (Group B) in which the maintainer was used during surgery. In the postoperative specimen, Micrococcus species were isolated from one eye (1.5%) in Group A and S. pyogenes in one eye (1.5%) from Group B. Mean follow-up interval was 12 +/- 6 (min = 4, max 28) months. CONCLUSIONS. The use of ACM system in clear corneal phacoemulsification surgery carries no additional risks as far as contamination is concerned. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Ophthalmology | en_US |
dc.subject | Phacoemulsification | en_US |
dc.subject | Anterior chamber contamination | en_US |
dc.subject | Anterior chamber maintainer | en_US |
dc.subject | Cataract-surgery | en_US |
dc.subject | Surgical technique | en_US |
dc.title | The effect of anterior chamber maintainer on anterior chamber contamination | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000187428400006 | tr_TR |
dc.identifier.scopus | 2-s2.0-1042290360 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Göz Hastalıkları Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 770 | tr_TR |
dc.identifier.endpage | 772 | tr_TR |
dc.identifier.volume | 13 | tr_TR |
dc.identifier.issue | 9-10 | tr_TR |
dc.relation.journal | European Journal of Ophthalmology | en_US |
dc.contributor.buuauthor | Baykara, Mehmet | - |
dc.contributor.buuauthor | Özakın, Cüneyt | - |
dc.contributor.buuauthor | Doğru, Murat | - |
dc.contributor.buuauthor | Ertürk, Haluk | - |
dc.contributor.buuauthor | Heper, Yasemin | - |
dc.contributor.buuauthor | Özçetin, Hikmet | - |
dc.contributor.researcherid | ABI-7051-2020 | tr_TR |
dc.contributor.researcherid | AAH-6506-2021 | tr_TR |
dc.identifier.pubmed | 14700097 | tr_TR |
dc.subject.wos | Ophthalmology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 23093006700 | tr_TR |
dc.contributor.scopusid | 57200678942 | tr_TR |
dc.contributor.scopusid | 7006540932 | tr_TR |
dc.contributor.scopusid | 7003716972 | tr_TR |
dc.contributor.scopusid | 56191003300 | tr_TR |
dc.contributor.scopusid | 6603402155 | tr_TR |
dc.subject.scopus | Endophthalmitis; Anti-Bacterial Agents; Cefuroxime | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Anterior chamber maintainer | en_US |
dc.subject.emtree | Anterior eye chamber disease | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Clinical trial | en_US |
dc.subject.emtree | Contamination | en_US |
dc.subject.emtree | Continuous infusion | en_US |
dc.subject.emtree | Controlled clinical trial | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Culture medium | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Micrococcus | en_US |
dc.subject.emtree | Phacoemulsification | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Agar | en_US |
dc.subject.emtree | Randomized controlled trial | en_US |
dc.subject.emtree | Surgical technique | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.